The trial missed its primary endpoint at 12 months but showed clinically meaningful benefits on VO2 peak and cardiac reserve not captured by standard measures.
Medscape Medical News
The trial missed its primary endpoint at 12 months but showed clinically meaningful benefits on VO2 peak and cardiac reserve not captured by standard measures.
Medscape Medical News
